NOX4 overexpression is a poor prognostic factor in patients undergoing curative esophagectomy for esophageal squamous cell carcinoma

Surgery - Tập 167 - Trang 620-627 - 2020
Yen-Hao Chen1,2,3, Hung-I. Lu4, Chien-Ming Lo4, Chang-Chun Hsiao2,5, Shau-Hsuan Li6
1Department of Hematology‑Oncology, Kaohsiung Chang Gung Memorial Hospital, and Chang Gung University College of Medicine, Kaohsiung, Taiwan
2Graduate Institute of Clinical Medical Sciences, College of Medicine, Chang Gung University, Taoyuan, Taiwan
3School of Medicine, Chung Shan Medical University, Taichung, Taiwan
4Department of Thoracic & Cardiovascular Surgery, Kaohsiung Chang Gung Memorial Hospital and Chang Gung University College of Medicine, Kaohsiung, Taiwan
5Division of Pulmonary and Critical Care Medicine, Kaohsiung Chang Gung Memorial Hospital, Kaohsiung, Taiwan
6Department of Hematology-Oncology, Kaohsiung Chang Gung Memorial Hospital and Chang Gung University College of Medicine, Kaohsiung, Taiwan

Tài liệu tham khảo

National Department of Health, Republic of China. Cancer Registry Annual Report 2015. Chen, 2017, Areca nut is associated with younger age of diagnosis, poor chemoradiotherapy response, and shorter overall survival in esophageal squamous cell carcinoma, PLoS One, 12 Chen, 2017, Treatment outcomes of patients with locally advanced synchronous esophageal and head/neck squamous cell carcinoma receiving curative concurrent chemoradiotherapy, Sci Rep, 7, 41785, 10.1038/srep41785 Hu, 1994, Risk factors for oesophageal cancer in northeast China, Int J Cancer, 57, 38, 10.1002/ijc.2910570108 Burmeister, 2005, Surgery alone versus chemoradiotherapy followed by surgery for resectable cancer of the oesophagus: a randomised controlled phase III trial, Lancet Oncol, 6, 659, 10.1016/S1470-2045(05)70288-6 Kelsen, 2007, Long-term results of RTOG trial 8911 (USA Intergroup 113): a random assignment trial comparison of chemotherapy followed by surgery compared with surgery alone for esophageal cancer, J Clin Oncol, 25, 3719, 10.1200/JCO.2006.10.4760 2002, Surgical resection with or without preoperative chemotherapy in oesophageal cancer: a randomised controlled trial, Lancet, 359, 1727, 10.1016/S0140-6736(02)08651-8 Cheng, 2001, Homologs of gp91phox: cloning and tissue expression of Nox3, Nox4, and Nox5, Gene, 269, 131, 10.1016/S0378-1119(01)00449-8 Lambeth, 2004, NOX enzymes and the biology of reactive oxygen, Nat Rev Immunol, 4, 181, 10.1038/nri1312 Bhandarkar, 2009, Fulvene-5 potently inhibits NADPH oxidase 4 and blocks the growth of endothelial tumors in mice, J Clin Invest, 119, 2359 Brar, 2003, NOX5 NAD(P)H oxidase regulates growth and apoptosis in DU 145 prostate cancer cells, Am J Physiol Cell Physiol, 285, C353, 10.1152/ajpcell.00525.2002 Chen, 2012, Atorvastatin reduces vascular endothelial growth factor (VEGF) expression in human non-small cell lung carcinomas (NSCLCs) via inhibition of reactive oxygen species (ROS) production, Mol Oncol, 6, 62, 10.1016/j.molonc.2011.11.003 Jajoo, 2009, Adenosine A(3) receptor suppresses prostate cancer metastasis by inhibiting NADPH oxidase activity, Neoplasia, 11, 1132, 10.1593/neo.09744 Chen, 2018, Nox4 overexpression as a poor prognostic factor in patients with oral tongue squamous cell carcinoma receiving surgical resection, J Clin Med, 7 Bauer, 2014, Proteomic and functional investigation of the colon cancer relapse-associated genes NOX4 and ITGA3, J Proteome Res, 13, 4910, 10.1021/pr500557n Paletta-Silva, 2013, NADPH oxidase biology and the regulation of tyrosine kinase receptor signaling and cancer drug cytotoxicity, Int J Mol Sci, 14, 3683, 10.3390/ijms14023683 Vaquero, 2004, Reactive oxygen species produced by NAD(P)H oxidase inhibit apoptosis in pancreatic cancer cells, J Biol Chem, 279, 34643, 10.1074/jbc.M400078200 Fitzgerald, 2012, Nox4 mediates renal cell carcinoma cell invasion through hypoxia-induced interleukin 6- and 8- production, PLoS One, 7, 10.1371/journal.pone.0030712 Helfinger, 2016, The NADPH Oxidase Nox4 mediates tumour angiogenesis, Acta Physiol (Oxf), 216, 435, 10.1111/apha.12625 Li, 2015, Reciprocal activation between IL-6/STAT3 and NOX4/Akt signalings promotes proliferation and survival of non-small cell lung cancer cells, Oncotarget, 6, 1031, 10.18632/oncotarget.2671 Crosas-Molist, 2014, The NADPH oxidase NOX4 inhibits hepatocyte proliferation and liver cancer progression, Free Radic Biol Med, 69, 338, 10.1016/j.freeradbiomed.2014.01.040 Fletcher, 2013, EGFR inhibition induces proinflammatory cytokines via NOX4 in HNSCC, Mol Cancer Res, 11, 1574, 10.1158/1541-7786.MCR-13-0187 Sanders, 2015, Epigenetic mechanisms regulate NADPH oxidase-4 expression in cellular senescence, Free Radic Biol Med, 79, 197, 10.1016/j.freeradbiomed.2014.12.008 Amin, 2017 Zhang, 2014, NOX4 promotes non-small cell lung cancer cell proliferation and metastasis through positive feedback regulation of PI3K/Akt signaling, Oncotarget, 5, 4392, 10.18632/oncotarget.2025 Mitsushita, 2004, The superoxide-generating oxidase Nox1 is functionally required for Ras oncogene transformation, Cancer Res, 64, 3580, 10.1158/0008-5472.CAN-03-3909 Liu, 2012, NADPH oxidase 1 overexpression enhances invasion via matrix metalloproteinase-2 and epithelial-mesenchymal transition in melanoma cells, J Invest Dermatol, 132, 2033, 10.1038/jid.2012.119 Guo, 2015, The human Nox4: gene, structure, physiological function and pathological significance, J Drug Target, 23, 888, 10.3109/1061186X.2015.1036276 Roy, 2015, NADPH oxidases and cancer, Clin Sci (Lond), 128, 863, 10.1042/CS20140542 Cheng, 2015, Metformin decreases growth of pancreatic cancer cells by decreasing reactive oxygen species: role of NOX4, Biochem Biophys Res Commun, 465, 41, 10.1016/j.bbrc.2015.07.118 Choi, 2016, Inhibition of breast cancer invasion by TIS21-Akt1-Sp1-Nox4 pathway targeting actin nucleators, mDia genes, Oncogene, 35, 83, 10.1038/onc.2015.64 Mochizuki, 2006, Inhibition of NADPH oxidase 4 activates apoptosis via the AKT/apoptosis signal-regulating kinase 1 pathway in pancreatic cancer PANC-1 cells, Oncogene, 25, 3699, 10.1038/sj.onc.1209406 Sun, 2016, MiR-99a regulates ROS-mediated invasion and migration of lung adenocarcinoma cells by targeting NOX4, Oncol Rep, 35, 2755, 10.3892/or.2016.4672